{"url_path":"/sec/sldb/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-12","source_url":"https://www.sec.gov/Archives/edgar/data/1707502/0001193125-26-219337-index.html","accession_number":"0001193125-26-219337","cik":"0001707502","ticker":"SLDB","issuer_name":"Solid Biosciences Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1707502/0001193125-26-219337-index.html","primary_entity_key":"0001707502","primary_entity_name":"Solid Biosciences Inc."},"word_count":40,"has_tables":true,"body_markdown":"Item 5. Other Information.\n\n(c) None of our directors or officers adopted or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement (as defined in Item 408(c) of Regulation S-K) during the first quarter of 2026.\n\n85"}